The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Carbon Medical Technologies sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Carbon Medical Technologies Inc (CMT) is a medical device company that develops, manufactures and markets carbon coated implantable medical instruments. The company’s products include radiopaque marking device for breast biopsies, fiducial marking device for radiation therapy, and durasphere exp. Its product durasphere EXP is used for the treatment of urinary incontinence. CMT’s products are used in tissue marking, soft tissue augmentation, and for vascular and neurological disorders. The company provides BiomarC tissue marker for the radiographical marking of soft tissue. It also offers research and development services for neurological embolizing coils, vascular stent coating, developing embolizing agent, and vocal cord reconstruction. The company’s products are used in various applications such as soft tissue augmentation, tissue marking, and for vascular and neurological disorders. CMT is headquartered in St. Paul, Minnesota, the US.
The key metrics of Carbon Medical Technologies related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Carbon Medical Technologies is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Carbon Medical Technologies.
For a detailed understanding of the performance of Carbon Medical Technologies, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
